Funder: National Institutes of Health

Due Dates: May 21, 2025 (LOI) | June 20, 2025 (Full) | Jan 21, 2026 (LOI) | Feb 20, 2026 (Full) | May 23, 2026 (LOI) | June 22, 2026 (Full)

Funding Amounts: No budget cap; up to 5 years per award; budgets must reflect actual project needs.

Summary: Supports rigorous clinical validation of candidate biomarkers for neurological or neuromuscular disorders, aligned with FDA standards.

Key Information: Candidate biomarker and detection method must already be identified and analytically validated; annual milestones required.